All are true about splenic marginal zone lymphoma, EXCEPT:
**Core Concept**
Splenic marginal zone lymphoma (SMZL) is a rare type of non-Hodgkin lymphoma that primarily affects the spleen. It is characterized by a distinct clinicopathological presentation and a relatively indolent clinical course. SMZL often presents with splenomegaly and can be associated with autoimmune hemolytic anemia.
**Why the Correct Answer is Right**
Splenic marginal zone lymphoma is often associated with autoimmune phenomena, including autoimmune hemolytic anemia (AIHA) and cold agglutinin disease. The lymphoma cells in SMZL can produce autoantibodies against red blood cells, leading to their destruction. The splenic involvement in SMZL is a result of the tumor cells accumulating in the marginal zone of the spleen, where they can proliferate and interact with the immune system.
**Why Each Wrong Option is Incorrect**
**Option A:** This option might be incorrect if it contradicts the established facts about SMZL, such as its association with autoimmune phenomena or its characteristic histological features.
**Option B:** This option might be incorrect if it suggests that SMZL is a more aggressive form of lymphoma than it actually is. SMZL is generally considered to be an indolent lymphoma, with a relatively slow clinical course.
**Option C:** This option might be incorrect if it implies that SMZL is not associated with splenomegaly. Splenomegaly is a common presenting feature of SMZL, and it is often due to the accumulation of tumor cells in the spleen.
**Option D:** This option might be incorrect if it contradicts the established facts about SMZL, such as its association with autoimmune phenomena or its characteristic histological features.
**Clinical Pearl / High-Yield Fact**
A key feature of SMZL is its association with autoimmune phenomena, including AIHA and cold agglutinin disease. This is due to the production of autoantibodies by the lymphoma cells, which can lead to the destruction of red blood cells.
**Correct Answer: A.**